These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33565118)

  • 41. Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments.
    Heisen M; Baeten SA; Verheggen BG; Stoelzel M; Hakimi Z; Ridder A; van Maanen R; Stolk EA
    Curr Med Res Opin; 2016; 32(4):787-96. PubMed ID: 26789823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
    Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
    J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient satisfaction with the benefits of overactive bladder treatment: exploration of influencing factors and development of a satisfaction assessment instrument.
    Zinner N; Kobashi K; Koochaki P; Fix D; Egermark M
    Neurourol Urodyn; 2011 Jan; 30(1):62-8. PubMed ID: 20860020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health and functional status, health events, use of healthcare services and costs associated with overactive bladder among the medically complex vulnerable elderly in the US.
    Chuang CC; Yang E; Zou KH; Araiza A; Wang A; Luo X
    Int J Clin Pract; 2019 Aug; 73(8):e13207. PubMed ID: 30011108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Care-Seeking for Stress Incontinence and Overactive Bladder Among Parous Women in the First Two Decades After Delivery.
    Fitzgerald J; Pierce C; Nugent J; Blomquist J; Handa VL
    Female Pelvic Med Reconstr Surg; 2016; 22(4):199-204. PubMed ID: 26945268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is overactive bladder independently associated with anxiety?
    Mutungi S; Parrish J; Maunder R; Alarab M; McDermott CD; Lemos N; Lovatsis D
    Int Urogynecol J; 2019 Oct; 30(10):1763-1769. PubMed ID: 31302716
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial.
    Herdman M; Nazir J; Hakimi Z; Siddiqui E; Huang M; Pavesi M; MacDiarmid S; Drake MJ; Devlin N
    Patient; 2017 Dec; 10(6):677-686. PubMed ID: 28646416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preference elicitation tool for abnormal uterine bleeding treatment: a randomized controlled trial.
    Hess LM; Litwiller A; Byron J; Stutsman J; Kasper K; Learman LA
    Patient; 2015 Apr; 8(2):217-27. PubMed ID: 25074354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatments for overactive bladder: focus on pharmacotherapy.
    Geoffrion R;
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis.
    Xu D; Zhao M; Huang L; Wang K
    Health Qual Life Outcomes; 2018 Jan; 16(1):1. PubMed ID: 29291738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment preference and patient centered prostate cancer care: Design and rationale.
    Jayadevappa R; Chhatre S; Gallo JJ; Wittink M; Morales KH; Bruce Malkowicz S; Lee D; Guzzo T; Caruso A; Van Arsdalen K; Wein AJ; Sanford Schwartz J
    Contemp Clin Trials; 2015 Nov; 45(Pt B):296-301. PubMed ID: 26435200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between the self-perception period of overactive bladder symptoms and overactive bladder symptom scores in a non-treated population and related sociodemographic and lifestyle factors.
    Kim JH; Ham BK; Shim SR; Lee WJ; Kim HJ; Kwon SS; Bae JH
    Int J Clin Pract; 2013 Aug; 67(8):795-800. PubMed ID: 23869680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping of the OAB-SF Questionnaire onto EQ-5D in Spanish Patients with Overactive Bladder.
    Ruiz MA; Gutiérrez LL; Monroy M; Rejas J
    Clin Drug Investig; 2016 Apr; 36(4):267-79. PubMed ID: 26860486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
    Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
    BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overactive Bladder Symptoms in Female Health Profession Students: Bladder Diary Characteristics and Impact of Symptoms on Health-Related Quality of Life.
    Reisch R; Rutt R; Dockter M; Sanders S
    J Womens Health (Larchmt); 2018 Feb; 27(2):156-161. PubMed ID: 28953429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Screening test for overactive bladder in a newly developed comprehensive geriatric assessment initiative].
    Sakai M; Akai T; Takata Y; Shimizu S; Koyama S; Iwamoto T
    Nihon Ronen Igakkai Zasshi; 2013; 50(2):249-57. PubMed ID: 23979249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sleep Disturbance and Fatigue Are Associated With More Severe Urinary Incontinence and Overactive Bladder Symptoms.
    Ge TJ; Vetter J; Lai HH
    Urology; 2017 Nov; 109():67-73. PubMed ID: 28826875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
    Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
    Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.